Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 10/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | CNR2 | P34972 | 1/20 | 0.35 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.34 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14154783 | 0.86 | CNR2 (0.42) | NPC1MAPTSMN1; SMN2RAB9AKDM4E | |
| SCHEMBL28485532 | 0.86 | CNR2 (0.42) | NPC1MAPTSMN1; SMN2RAB9AKDM4E | |
| SCHEMBL14821169 | 0.86 | CNR2 (0.42) | NPC1MAPTSMN1; SMN2RAB9AKDM4E | |
| Hydrochloric Acid SCHEMBL7176559 | 0.83 | CNR2 (0.41) | NPC1MAPTSMN1; SMN2RAB9AKDM4E | |
| Hydrochloric Acid SCHEMBL7176423 | 0.83 | CNR2 (0.41) | NPC1MAPTSMN1; SMN2RAB9AKDM4E | |
| Hydrochloric Acid SCHEMBL7176684 | 0.83 | CNR2 (0.41) | NPC1MAPTSMN1; SMN2RAB9AKDM4E | |
| Hydrochloric Acid SCHEMBL7183257 | 0.83 | CNR2 (0.41) | NPC1MAPTSMN1; SMN2RAB9AKDM4E | |
| Hydrochloric Acid SCHEMBL7183592 | 0.83 | CNR2 (0.41) | NPC1MAPTSMN1; SMN2RAB9AKDM4E | |
| Hydrochloric Acid SCHEMBL7180528 | 0.83 | CNR2 (0.41) | NPC1MAPTSMN1; SMN2RAB9AKDM4E | |
| SCHEMBL757124 | 0.81 | RAB9A (0.46) | NPC1MAPTSMN1; SMN2RAB9AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8138348-B2 | Using coordination polymerization catalyst | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2012-03-20 | — | — | US | disclosed |
| US-8138348-B2 | Using coordination polymerization catalyst | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2012-03-20 | — | — | US | disclosed |
| US-20080182989-A1 | Methods For Oligomerizing Olefins With Chromium Pyridine Mono-Oxazoline Catalysts | EXXONMOBIL CHEMICAL PATENTS INC. | 2008-07-31 | — | — | US | disclosed |
| US-20080182989-A1 | Methods For Oligomerizing Olefins With Chromium Pyridine Mono-Oxazoline Catalysts | EXXONMOBIL CHEMICAL PATENTS INC. | 2008-07-31 | — | — | US | disclosed |
| WO-2008085655-A1 | METHODS FOR OLIGOMERIZING OLEFINS WITH CHROMIUM PYRIDINE MONO-OXAZOLINE CATALYSTS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2008-07-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080182989-A1 | Methods For Oligomerizing Olefins With Chromium Pyridine Mono-Oxazoline Catalysts | OXER1, OXGR1, OXA1L | NPC1 3998/4885MAPT 2924/4885SMN1; SMN2 1823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.